Literature DB >> 3193843

Characterization of muscarinic receptor subtypes in human tissues.

E Giraldo1, F Martos, A Gomez, A Garcia, M A Vigano, H Ladinsky, F Sanchez de La Cuesta.   

Abstract

The affinities of selective, pirenzepine and AF-DX 116, and classical, N-methylscopolamine and atropine, muscarinic cholinergic receptor antagonists were investigated in displacement binding experiments with [3H]Pirenzepine and [3H]N-methylscopolamine in membranes from human autoptic tissues (forebrain, cerebellum, atria, ventricle and submaxillary salivary glands). Affinity estimates of N-methylscopolamine and atropine indicated a non-selective profile. Pirenzepine showed differentiation between the M1 neuronal receptor of the forebrain and the receptors in other tissues while AF-DX 116 clearly discriminated between muscarinic receptors of heart and glands. The results in human tissues confirm the previously described selectivity profiles of pirenzepine and AF-DX 116 in rat tissues. These findings thus reveal the presence also in man of three distinct muscarinic receptor subtypes: the neuronal M1, the cardiac M2 and the glandular M3.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193843     DOI: 10.1016/0024-3205(88)90398-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Functional M3 muscarinic acetylcholine receptors in mammalian hearts.

Authors:  Zhiguo Wang; Hong Shi; Huizhen Wang
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

2.  M(3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice.

Authors:  Takeshi Nakamura; Minoru Matsui; Keiko Uchida; Akira Futatsugi; Shinji Kusakawa; Nagisa Matsumoto; Kyoko Nakamura; Toshiya Manabe; Makoto M Taketo; Katsuhiko Mikoshiba
Journal:  J Physiol       Date:  2004-05-14       Impact factor: 5.182

3.  Muscarinic cholinoceptors in the human heart: demonstration, subclassification, and distribution.

Authors:  N M Deighton; S Motomura; D Borquez; H R Zerkowski; N Doetsch; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

4.  Cardiac muscarinic receptors decrease with age. In vitro and in vivo studies.

Authors:  O E Brodde; U Konschak; K Becker; F Rüter; U Poller; J Jakubetz; J Radke; H R Zerkowski
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

5.  Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.

Authors:  Tomomi Oki; Shuichi Sato; Keiji Miyata; Shizuo Yamada
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

6.  Role of muscarinic receptor subtypes in central antinociception.

Authors:  A Bartolini; C Ghelardini; L Fantetti; M Malcangio; P Malmberg-Aiello; A Giotti
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

Review 7.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

8.  Chronic beta 1-adrenoceptor antagonist treatment sensitizes beta 2-adrenoceptors, but desensitizes M2-muscarinic receptors in the human right atrium.

Authors:  S Motomura; N M Deighton; H R Zerkowski; N Doetsch; M C Michel; O E Brodde
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

9.  Salivary glands regenerate after radiation injury through SOX2-mediated secretory cell replacement.

Authors:  Elaine Emmerson; Alison J May; Lionel Berthoin; Noel Cruz-Pacheco; Sara Nathan; Aaron J Mattingly; Jolie L Chang; William R Ryan; Aaron D Tward; Sarah M Knox
Journal:  EMBO Mol Med       Date:  2018-03       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.